Standard regulatory tests under GLP
We carry out regulatory genotoxicity and (cyto)toxicity analysis as part of a battery of tests which can be adapted according to your needs, your product and according to regulatory requirements or the stage of development of your product.
REGULATORY TESTS | DOCUMENTS (FR) | DOCUMENTS (EN) |
---|---|---|
Bacterial Gene mutation test (Ames test) | OCDE 471 | OECD 471 |
In vitro chromosome aberration test on mammalian cells | OCDE 473 | OECD 473 |
In vitro gene mutation test in L5178Y mouse lymphoma cells (MLA/TK) or in human TK6 cells | OCDE 490 | OECD 490 |
In vitro micronucleus test in mammalian cells | OCDE 487 | OECD 487 |
In vitro skin irritation: reconstituted human epidermis test method | OCDE 439 | OECD 439 |
In vitro skin corrosion: human skin model test | OCDE 431 | OECD 431 |
Bhas 42 cell transformation test (according to ENV/JM/MONO [2016]1) | ||
Cytotoxicity test by MTT or neutral red method (biomaterials) (according to NF EN 30993-5/ISO 10993-5) | ||
Bone marrow micronucleus in vivo test | OCDE 474 | OECD 474 |
In vivo comet assay | OCDE 489 | OECD 489 |
Acute toxicity – acute toxic class method | OCDE 423 | OECD 423 |
Contact us
If you would like to know more about our GLP standard regulatory tests, get in touch now using the contact form below. We will get back to you as soon as possible.